《业绩》天津发展(00882.HK)附属力生制药去年赚1.85亿人币 按年跌49%

阿斯达克财经
21 Mar

天津发展(00882.HK) 公布,深交所上市附属公司力生制药(002393.SZ) 截至去年12月底止全年业绩,营业总收入13.36亿元人民币(下同),按年升15.9%;归属于母公司所有者净利润1.85亿元,按年跌49%;每股盈利0.72元。(js/j)(港股报价延迟最少十五分钟。) (A股报价延迟最少十五分钟。)

过往派息
公布日期派息事项派息内容
2024/08/29中期业绩股息:港元 0.0518
2024/03/27末期业绩股息:港元 0.0880
2023/08/30中期业绩股息:港元 0.0345
2023/03/30末期业绩股息:港元 0.0550

AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10